{"id":123290,"date":"2020-12-01T00:02:26","date_gmt":"2020-11-30T21:02:26","guid":{"rendered":"https:\/\/en.buradabiliyorum.com\/more-affordable-alzheimers-blood-test-now-available-despite-concerns\/"},"modified":"2020-12-01T00:02:26","modified_gmt":"2020-11-30T21:02:26","slug":"more-affordable-alzheimers-blood-test-now-available-despite-concerns","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/more-affordable-alzheimers-blood-test-now-available-despite-concerns\/","title":{"rendered":"#More affordable Alzheimer\u2019s blood test now available, despite concerns"},"content":{"rendered":"

“#More affordable Alzheimer\u2019s blood test now available, despite concerns<\/strong>”
\n<\/p>\n

\n A first-of-its-kind blood test for Alzheimer\u2019s disease is now on sale, signaling a potential breakthrough for patients but also raising concerns.<\/p>\n

The test from C2N Diagnostics of St. Louis determines if patients have a buildup of a protein called beta-amyloid in the brain, evidence that is key to a dementia diagnosis.<\/p>\n

Currently, the best way to measure that is a costly PET brain scan that most patients avoid because it is not usually covered by insurance, leaving many doctors and patients with unanswered questions about the cause of memory loss symptoms.<\/p>\n

Independent experts remain skeptical about the new blood examination because key test results have not been published, and the test has not yet been app<\/a>roved by the US Food and Drug Administration \u2014 giving rise to questions about its accuracy and the impact of a potentially false life-changing result.<\/p>\n

Despite concerns, doctors agree that a simple test in a doctors office is long overdue.<\/p>\n

Tammy Maida, 63, told the Associated Press<\/a> such a test could have saved her a decade\u2019s-worth of trip<\/a>s to doctors who chalked up her symptoms to depression, anxiety or menopause before a $5,000 brain scan last year finally showed she had Alzheimer\u2019s.<\/p>\n

\u201cI now have an answer,\u201d said the former California nurse.<\/p>\n

The new test is intended for people 60 and older who suffer from thinking problems and are being evaluated for Alzheimer\u2019s. It\u2019s not covered by insurance or Medicare, and costs $1,250 with discounts on a sliding scale for low-income patients. Results are available within 10 days from a doctor.<\/p>\n

C2N Diagnostics is seeking FDA approval and is defending its choice to begin selling the tests before results of the government review can be published.<\/p>\n

\u201cShould we be holding that technology<\/a> back when it could have a big impact on patient care?\u201d the company\u2019s chief executive Dr. Joel Braunstein asked.<\/p>\n

Company promotional materials<\/a> cite results that the test can correctly identify brain amyloid plaque status with an 86 percent accuracy rate comparing to PET brain scans.<\/p>\n

It\u2019s estimated that 44 million people<\/a> around the world suffer from Alzheimer\u2019s or a related form of dementia.<\/p>\n

With AP wires<\/em>\n <\/div>\n

If you liked the article, do not forget to share it with your friends. Follow us on\u00a0Google News<\/a><\/span>\u00a0too, click on the star and choose us from your favorites.<\/span><\/strong><\/p><\/blockquote>\n

\n

For forums sites go to Forum.BuradaBiliyorum.Com<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n

\n

If you want to read more News<\/a> articles, you can visit our News category.<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n

Source<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

“#More affordable Alzheimer\u2019s blood test now available, despite concerns” A first-of-its-kind blood test for Alzheimer\u2019s disease is now on sale, signaling a potential breakthrough for patients but also raising concerns. The test from C2N Diagnostics of St. Louis determines if patients have a buildup of a protein called beta-amyloid in the brain, evidence that is…<\/p>\n","protected":false},"author":1,"featured_media":123291,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/nypost.com\/wp-content\/uploads\/sites\/2\/2020\/11\/AlzheimersBloodTest.jpg?quality=90&strip=all&w=1200","fifu_image_alt":"","footnotes":""},"categories":[70897],"tags":[82193,70284,82265],"class_list":["post-123290","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-11-30-20","tag-alzheimers-disease","tag-blood-tests"],"_links":{"self":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/123290","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/comments?post=123290"}],"version-history":[{"count":0,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/123290\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media\/123291"}],"wp:attachment":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media?parent=123290"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/categories?post=123290"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/tags?post=123290"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}